[1] |
Mccullough RW. US oncology-wide incidence, duration, costs and deaths from chemoradiation mucositis and antimucositis therapy benefits[J]. Future Oncol, 2017,13(30):2823-2852. doi: 10.2217/fon-2017-0418.
DOI
URL
|
[2] |
Thomsen M, Vitetta L. Adjunctive treatments for the prevention of chemotherapy- and Radiotherapy-Induced mucositis[J]. Integr Cancer Ther, 2018,17(4):1027-1047. doi: 10.1177/1534735418794 885.
DOI
URL
|
[3] |
Sonis ST. Oral mucositis[J]. Anticancer Drugs, 2011,22(7):607-612. doi: 10.1097/CAD.0b013e3283462086.
DOI
URL
|
[4] |
Alexander JL, Wilson ID, Teare J, et al. Gut microbiota modulation of chemotherapy efficacy and toxicity[J]. Nat Rev Gastroenterol Hepatol, 2017,14(6):356-365. doi: 10.1038/nrgastro.2017.20.
DOI
PMID
|
[5] |
Hong BY, Sobue T, Choquette L, et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis[J]. Microbiome, 2019,7(1):66. doi: 10.1186/s40168-019-0679-5.
DOI
URL
|
[6] |
Hou J, Zheng H, Li P, et al. Distinct shifts in the oral microbiota are associated with the progression and aggravation of mucositis during radiotherapy[J]. Radiother Oncol, 2018,129(1):44-51. doi: 10.1016/j.radonc.2018.04.023.
DOI
URL
|
[7] |
Zhu XX, Yang XJ, Chao YL, et al. The potential effect of oral microbiota in the prediction of mucositis during radiotherapy for nasopharyngeal carcinoma[J]. EBioMedicine, 2017,18(18):23-31. doi: 10.1016/j.ebiom.2017.02.002.
DOI
URL
|
[8] |
Vesty A, Gear K, Biswas K, et al. Oral microbial influences on oral mucositis during radiotherapy treatment of head and neck cancer[J]. Support Care Cancer, 2020,28(6):2683-2691. doi: 10.1007/s00520-019-05084-6.
DOI
PMID
|
[9] |
Vasconcelos RM, Sanfilippo N, Paster BJ, et al. Host-Microbiome cross-talk in oral mucositis[J]. J Dent Res, 2016,95(7):725-733. doi: 10.1177/0022034516641890.
DOI
URL
|
[10] |
Vanlancker E, Vanhoecke B, Sieprath T, et al. Oral microbiota reduce wound healing capacity of epithelial monolayers, irrespective of the presence of 5-fluorouracil[J]. Exp Biol Med (Maywood), 2018,243(4):350-360. doi: 10.1177/1535370217753842.
DOI
URL
|
[11] |
Vanhoecke BW, De Ryck TR, De BK, et al. Low-dose irradiation affects the functional behavior of oral microbiota in the context of mucositis[J]. Exp Biol Med (Maywood), 2016,241(1):60-70. doi: 10.1177/1535370215595467.
DOI
URL
|
[12] |
Li HL, Lu L, Wang XS, et al. Alteration of gut microbiota and inflammatory cytokine/chemokine profiles in 5-fluorouracil induced intestinal mucositis[J]. Front Cell Infect Microbiol, 2017,7:455. doi: 10.3389/fcimb.2017.00455.
DOI
URL
|
[13] |
Gerassy-Vainberg S, Blatt A, Danin-Poleg Y, et al. Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction[J]. Gut, 2018,67(1):97-107. doi: 10.1136/gutjnl-2017-313789.
DOI
PMID
|
[14] |
Markowiak P, Slizewska K. Effects of probiotics, prebiotics, and synbiotics on human health[J]. Nutrients, 2017,9(9):1021. doi: 10.3390/nu9091021.
DOI
URL
|
[15] |
Seminario-Amez M, López-López J, Estrugo-Devesa A, et al. Probiotics and oral health: a systematic review[J]. Med Oral Patol Oral Cir Bucal, 2017,22(3):e282-e288. doi: 10.4317/medoral.21494.
DOI
|
[16] |
Batista VL, da Silva TF, de Jesus LCL, et al. Probiotics, prebiotics, synbiotics, and paraprobiotics as a therapeutic alternative for intestinal mucositis[J]. Front Microbiol, 2020,11:544490. doi: 10.3389/fmicb.2020.544490.
DOI
URL
|
[17] |
Gerhard D, Sousa F, Andraus RAC, et al. Probiotic therapy reduces inflammation and improves intestinal morphology in rats with induced oral mucositis[J]. Braz Oral Res, 2017,31:e71. doi: 10.1590/1807-3107BOR-2017.vol31.0071.
DOI
|
[18] |
Gupta N, Ferreira J, Hong CHL, et al. Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis[J]. Sci Rep, 2020,10(1):16189. doi: 10.1038/s41598-020-73292-w.
DOI
URL
|
[19] |
Sharma A, Rath GK, Chaudhary SP, et al. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study[J]. Eur J Cancer, 2012,48(6):875-881. doi: 10.1016/j.ejca.2011.06.010.
DOI
URL
|
[20] |
Sharma A, Tilak T, Bakhshi S, et al. Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation[J]. ESMO Open, 2016,1(6):e000138. doi: 10.1136/esmoopen-2016-000138.
DOI
URL
|
[21] |
De Sanctis V, Belgioia L, Cante D, et al. Lactobacillus brevis CD2 for prevention of oral mucositis in patients with head and neck tumors: a multicentric randomized study[J]. Anticancer Res, 2019,39(4):1935-1942. doi: 10.21873/anticanres.13303.
DOI
URL
|
[22] |
Limaye SA, Haddad RI, Cilli F, et al. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy[J]. Cancer, 2013,119(24):4268-4276. doi: 10.1002/cncr.28365.
DOI
URL
|
[23] |
Jiang C, Wang H, Xia C, et al. A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma[J]. Cancer, 2019,125(7):1081-1090. doi: 10.1002/cncr.31907.
DOI
URL
|
[24] |
Oh NS, Jy L, Lee JM, et al. Mulberry leaf extract fermented with Lactobacillus acidophilus A4 ameliorates 5-fluorouracil-induced intestinal mucositis in rats[J]. Lett Appl Microbiol, 2017,64(6):459-468. doi: 10.1111/lam.12741.
DOI
URL
|
[25] |
Kato S, Hamouda N, Kano Y, et al. Probiotic bifidobacterium bifidum G9-1 attenuates 5-fluorouracil-induced intestinal mucositis in mice via suppression of dysbiosis-related secondary inflammatory responses[J]. Clin Exp Pharmacol Physiol, 2017,44(10):1017-1025. doi: 10.1111/1440-1681.12792.
DOI
URL
|
[26] |
Chang CW, Liu CY, Lee HC, et al. Lactobacillus casei variety rhamnosus probiotic preventively attenuates 5-fluorouracil/oxaliplatin-induced intestinal injury in a syngeneic colorectal cancer model[J]. Front Microbiol, 2018,9:983. doi: 10.3389/fmicb.2018. 00983.
DOI
URL
|
[27] |
Huang L, Chiang CJ, Cheng ML, et al. SCID/NOD mice model for 5-FU induced intestinal mucositis: Safety and effects of probiotics as therapy[J]. Pediatr Neonatol, 2019,60(3):252-260. doi: 10.1016/j.pedneo.2018.07.007.
DOI
URL
|
[28] |
Mi H, Dong Y, Zhang B, et al. Bifidobacterium infantis ameliorates chemotherapy-induced intestinal mucositis via regulating T cell immunity in colorectal cancer rats[J]. Cell Physiol Biochem, 2017,42(6):2330-2341. doi: 10.1159/000480005.
DOI
URL
|
[29] |
Maioli TU, de Melo Silva B, Dias MN, et al. Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice[J]. J Negat Results Biomed, 2014,13(1):6. doi: 10.1186/1477-5751-13-6.
DOI
URL
|
[30] |
Tang Y, Wu Y, Huang Z, et al. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats[J]. Nutrition, 2017,33:96-104. doi: 10.1016/j.nut.2016.05.003.
DOI
PMID
|
[31] |
Quaresma M, Damasceno S, Monteiro C, et al. Probiotic mixture containing Lactobacillus spp. and Bifidobacterium spp. attenuates 5-fluorouracil-induced intestinal mucositis in mice[J]. Nutr Cancer, 2020,72(8):1355-1365. doi: 10.1080/01635581.2019.1675719.
DOI
URL
|
[32] |
Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy[J]. Cancer, 2014,120(10):1453-1461. doi: 10.1002/cncr.28592.
DOI
URL
|
[33] |
Osterlund P, Ruotsalainen T, Korpela R, et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study[J]. Br J Cancer, 2007,97(8):1028-1034. doi: 10.1038/sj.bjc.6603990.
DOI
URL
|
[34] |
Motoori M, Yano M, Miyata H, et al. Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients[J]. Clin Nutr, 2017,36(1):93-99. doi: 10.1016/j.clnu.2015.11.008.
DOI
URL
|
[35] |
Wardill HR, Van Sebille YZA, Ciorba MA, et al. Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis[J]. Curr Opin Support Palliat Care, 2018,12(2):187-197. doi: 10.1097/SPC.0000000000000338.
DOI
PMID
|
[36] |
Ladas EJ, Bhatia M, Chen L, et al. The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation[J]. Bone Marrow Transplant, 2016,51(2):262-266. doi: 10.1038/bmt.2015.275.
DOI
URL
|